Think.Health
Venture capitalBerlin · Seed–Growth · 3 people tracked
Investment thesis
Think Health invests in early-stage and growth ventures across the healthcare sector, viewing it as a persistent megatrend creating opportunities for innovative business models. The firm focuses on companies developing digital health technologies, medical devices, diagnostics, and therapeutic solutions. Think Health combines deep healthcare industry expertise with investment experience, providing hands-on support, access to an extensive professional network, and coaching from experienced healthcare practitioners to help portfolio companies scale.
Source: firm website, verified Jul 21, 2026.
Team · 3 people
from the firm's websiteFlorian Kainzinger brings over 20 years of healthcare management experience, including tenure as CEO of Labor Berlin with oversight of 500+ employees across 12 sites. Prior roles include positions at Roland Berger Strategy Consultants advising hospitals and pharmaceutical companies.
Michael Ruoff is an attorney and private equity professional with over 20 years of experience, including work as partner in international law firms and in-house counsel. His track record includes involvement in more than 50 successful M&A and investment transactions across venture capital and leveraged buyout transactions.
Nils Bottler has over 10 years of startup investment and operational support experience through involvement with incubators, accelerators, and corporate venture capital units. His background also includes M&A work at a boutique private bank and an MBA from Cambridge University.
Investments · 24 tracked
founders shown can be your intro pathDevelops and manufactures fluidlab, a point-of-care testing platform for veterinarians, scientists, and medical professionals.
Advances the medical cannabis market in Germany with a focus on patient access to medical cannabis therapy.
A digital therapy assistant providing 24/7 communication and monitoring tools for therapists and patients in rehabilitation medicine.
A biotech company pioneering synthetic biopsy technology for ultra-early cancer detection through engineered genetic constructs.
Develops innovative products and procedures for dentistry, including solutions to improve root canal filling success rates and reduce treatment time.
Develops innovative diagnostic products for rapid and cost-effective detection of life-threatening infections with effective therapy determination.
Offers professional senior home care services for private households, hospitals, and insurance companies.
Provides innovative hygiene management solutions for hospitals and healthcare institutions to improve hand hygiene and prevent infections.
Develops rapid molecular diagnostic tests that read immune system response for diagnosing acute infections and sepsis.
A certified medical app offering personalized digital assistance for migraine and headache management with medical guidelines and in-app therapy.
A messenger platform for elderly care that connects caregivers to residents' relatives with transactional services.
Develops solutions to identify optimal cancer treatments for individual patients through services for pharmaceutical companies and companion diagnostic development.
A pharmaceutical wholesaler distributing medicinal products to pharmacies for patient-specific cancer drug production with quality assurance services.
A digital pathology platform that digitizes histologic slides and distributes workload to expert dermatopathologists for remote consultation and skin cancer diagnosis.
A pan-European supplier of specialized medical cannabis therapy products with expertise in medical marijuana treatment.
A digital health platform that transforms veterinary care through integration of pet health records, online booking, and AI-assisted documentation.
Develops and sells innovative sample preparation technologies and tools for mass spectrometer-based protein analysis.
Develops neurosurgical microrobots for minimally invasive diagnosis, treatment, and monitoring of brain diseases.
Provides online therapy programs combining digital courses with psychologist support to address mental health disorders including depression, anxiety, and eating disorders.
Develops surgical gloves with double barrier and marker functionality to enhance protection and reduce infection risks.
Develops in vitro diagnostic solutions with proprietary assays for novel blood-based biomarkers including kidney function and endothelial function assessment.
Develops a point-of-care diagnostic system based on proprietary microfluidic technology for rapid infectious disease testing.
Provides membership access to fitness studios, sports classes, and health activities across a network of partner facilities in Germany.
A workflow optimization software platform for outpatient radiology centers with AI-assisted breast cancer screening and automated reporting.
Frequently asked questions
- What stage does Think.Health invest at?
- Think.Health invests at the Seed, Series A, Series B, Growth stages.
- What is Think.Health's typical check size?
- Think.Health typically writes checks of $545K – $10.9M.
- What sectors does Think.Health focus on?
- Think.Health focuses on Biotech, Digital Health, Healthtech, Medical Devices, Mental Health.
- Where is Think.Health located?
- Think.Health is headquartered in Berlin.
Similar investors
B Capital is a venture capital firm managing over $12 billion in assets with a stage-based fund approach. The firm invests across early to late-stage companies in technology, healthcare, and energy & resilience sectors, with 200+ portfolio companies and 9 global offices.
Breyer Capital is a venture capital firm that invests in high-impact entrepreneurs with a strategic focus on companies leveraging artificial intelligence and machine learning to transform technology sectors globally.
DCVC is a deep tech venture capital firm with over a dozen years of experience backing entrepreneurs using computational approaches to solve trillion-dollar problems across industries including AI, climate, materials science, robotics, space, and biology.
GV is Alphabet's venture capital arm, established in 2009 as Google Ventures. Operating with long time horizons and over $13 billion in assets under management, the firm invests across technology and life sciences sectors from seed to growth stages, supporting 400 active portfolio companies across North America, Europe, and Israel.
Innovestor is a Finnish investment manager that operates across venture capital, real estate, and energy storage sectors. The firm invests in early-stage technology and life science startups, energy-efficient commercial real estate, and battery storage and solar solutions. Innovestor also provides corporate venturing advisory services.